PAVM - PAVmed gets European CE Mark for Carpx minimally invasive carpal tunnel device

PAVmed ([[PAVM]] +1.9%) announces that it has received CE Mark certification for its CarpX minimally invasive carpal tunnel device.With CE Mark secured, CarpX may now be marketed in CE Mark European countries, which include the European Economic Area (the EU, Norway, Iceland and Lichtenstein), Switzerland, and, until July 1, 2023, the United Kingdom, the company said."Carpal tunnel syndrome is widely prevalent in Europe and the estimated total addressable market opportunity for CarpX there is at least as large as in the U.S. We look forward to moving towards commercial launch in select European countries in the near future," CEO Lishan Aklog said.

For further details see:

PAVmed gets European CE Mark for Carpx minimally invasive carpal tunnel device